The ART of decision making: retreatment with transarterial chemoembolization in patients with hepatocellular carcinoma.
about
Usefulness of staging systems and prognostic scores for hepatocellular carcinoma treatmentsBrazilian society of hepatology recommendations for the diagnosis and treatment of hepatocellular carcinomaTransarterial chemoembolization: Evidences from the literature and applications in hepatocellular carcinoma patientsRecent advances in multidisciplinary management of hepatocellular carcinomaTreatment of hepatocellular carcinoma: Steps forward but still a long way to goDrug therapy for advanced-stage liver cancerRecommendations for the use of chemoembolization in patients with hepatocellular carcinoma: Usefulness of scoring system?Cancer and liver cirrhosis: implications on prognosis and managementTransarterial Therapies for Hepatocellular CarcinomaBarcelona clinic liver cancer nomogram and others staging/scoring systems in a French hepatocellular carcinoma cohortPredictors of repeat transarterial chemoembolization in the treatment of hepatocellular carcinomaTransarterial embolization therapies for the treatment of hepatocellular carcinoma: CEPO review and clinical recommendationsAdjuvant stereotactic body radiotherapy following transarterial chemoembolization in patients with non-resectable hepatocellular carcinoma tumours of ≥ 3 cmA prognostic score for patients with intermediate-stage hepatocellular carcinoma treated with transarterial chemoembolization.RMP predicts survival and adjuvant TACE response in hepatocellular carcinoma.Pharmacokinetic study of conventional sorafenib chemoembolization in a rabbit VX2 liver tumor model.Management of Hepatocellular Carcinoma: Current Status and Future Directions.Comparison of Existing Response Criteria in Patients with Hepatocellular Carcinoma Treated with Transarterial Chemoembolization Using a 3D Quantitative Approach.Modified transarterial chemoembolization with locoregional administration of sorafenib for treating hepatocellular carcinoma: feasibility, efficacy, and safety in the VX-2 rabbit liver tumor modelThe Effectiveness of ART Score in Selecting Patients for Transarterial Chemoembolization Retreatment: A Cohort Study in Taiwan.Combined sequential use of HAP and ART scores to predict survival outcome and treatment failure following chemoembolization in hepatocellular carcinoma: a multi-center comparative studyNovel implications in the treatment of hepatocellular carcinoma.Postsurgical treatment with adjuvant transarterial chemoembolization in patients with hepatitis B-related hepatocellular carcinoma: A strobe-compliant article.Three-dimensional conformal radiotherapy for locally advanced hepatocellular carcinoma with portal vein tumour thrombosis: evaluating effectiveness of the model for end-stage liver disease (MELD) score compared with the Child-Pugh classification.Prognostic nomogram for post-surgical treatment with adjuvant TACE in hepatitis B virus-related hepatocellular carcinoma.Transarterial chemoembolization and bland embolization for hepatocellular carcinoma.Development of systemic therapy for hepatocellular carcinoma at 2013: updates and insights.Hepatocellular carcinoma review: current treatment, and evidence-based medicine.How to define transarterial chemoembolization failure or refractoriness: a European perspectiveTreatment of intermediate-stage hepatocellular carcinoma.Evolution from WHO to EASL and mRECIST for hepatocellular carcinoma: considerations for tumor response assessment.Managing complications in cirrhotic patientsTreatment of Liver Tumors with Lipiodol TACE: Technical Recommendations from Experts Opinion.Nomogram for individualized prediction of recurrence after postoperative adjuvant TACE for hepatitis B virus-related hepatocellular carcinoma.Reassessing the boundaries of liver transplantation for hepatocellular carcinoma: Where do we stand with tumor down-staging?New concepts in embolotherapy of HCC.Transarterial chemoembolization for hepatocellular carcinoma: an evidence-based review of its place in therapy.Review article: delivering precision oncology in intermediate-stage liver cancer.Plasma micoRNA-122 as a predictive marker for treatment response following transarterial chemoembolization in patients with hepatocellular carcinoma.Target lesion response predicts survival of patients with hepatocellular carcinoma retreated with transarterial chemoembolization.
P2860
Q26743666-6523BC16-DA51-4C7E-B9BD-4AFE9E95D767Q26766707-8C579084-0822-42E3-8A1C-33A72072D384Q26799469-1F161CE7-DC65-4610-809E-A88CFC4845C8Q26863748-15D6B1F7-C081-4153-B164-C35A5C63007AQ26865456-768CCD99-D60F-4FC1-8990-8876395951CBQ27004410-02D79059-6AC4-45CE-8482-88F84A191F31Q27022015-FC311C86-AA27-4C3A-B438-39F7C71497A2Q28068579-E7C4E1EB-3EBB-414B-9C69-2A59A5EECF4FQ28072845-E7119267-2B60-46ED-AFFC-25A2192DE7F4Q33572657-74710889-F07C-48ED-9EF5-74DF8DCF5EB3Q34618735-4DEFA0C6-8EBC-47AF-BDAA-022AD2F8F600Q34702094-610F7EE7-0BEA-4455-B45C-40E58BFA9FCCQ34986180-EB69CDA6-F6E8-48DA-B409-8676F4A9383FQ35546984-7C9B1A03-C2DE-4ECE-AF93-D41F84CD6A1DQ35550266-D64CEA36-138E-4DC8-8AC1-9084A5B68FF9Q35720473-97C7793F-C066-48D5-B36C-429AA6D17921Q35771842-CB5441F9-7BF8-432E-8D9F-65225AF723ADQ36416250-27E598EA-DA93-4CFB-84B4-E093D2D8C528Q37114870-07DE1960-38B8-4B0F-9216-9E6540CB8E2FQ37328442-F309FC17-1888-417B-BA3E-299D584AC694Q37537007-4D9842FE-27B2-4D1D-870D-9F8DC59A4202Q37542835-3AE3D813-E7CA-49EF-9D3A-9A00D6FF0776Q37552069-E1A4EA99-79EE-4DD3-B310-462D1A2E6622Q37600883-C0F759C2-0F73-478F-8AE9-C561328F6CA4Q37629021-38F6F1D0-4105-429A-B84F-45A00E07B9EDQ38201633-4CED1ED9-0AB5-4B0D-AD3B-DDA31E10E77AQ38201707-07915EA4-438B-400F-9CB6-B54EA95D5659Q38207012-A991CA96-E86B-4869-AABB-F56F465B63D2Q38221512-601E6EFE-D837-4ACB-8BA2-38E08D816A05Q38236876-775DB816-DC9D-410E-A450-88DE814A9C3FQ38265024-801CC1CF-01AA-4CB4-A450-F6BA8F5C3ACCQ38344890-838404A0-2E29-46EA-A4E7-B1F0145082F6Q38590448-1491BBF0-6FF5-4B6D-9D7F-1538A826570DQ38630820-DB997C14-E6D6-45BA-9823-2E21DA7DA7E8Q38631276-EA2525C6-F872-4F36-82DF-A43E254E626BQ38904263-69D27CAB-E3F9-4B58-AB5F-F831A0985364Q38923548-03CBCD9C-3A33-497D-8128-1F3B8C7F260BQ39261082-6A9D78CF-3D53-4F20-8639-5FC26B086A2AQ39754560-580D3A74-482D-45F9-8ECA-F02D7D507175Q39830114-A0329EDD-7BB9-445B-8540-9739EAF5A8C0
P2860
The ART of decision making: retreatment with transarterial chemoembolization in patients with hepatocellular carcinoma.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
The ART of decision making: re ...... with hepatocellular carcinoma.
@en
The ART of decision making: re ...... with hepatocellular carcinoma.
@nl
type
label
The ART of decision making: re ...... with hepatocellular carcinoma.
@en
The ART of decision making: re ...... with hepatocellular carcinoma.
@nl
prefLabel
The ART of decision making: re ...... with hepatocellular carcinoma.
@en
The ART of decision making: re ...... with hepatocellular carcinoma.
@nl
P2093
P2860
P356
P1433
P1476
The ART of decision making: re ...... with hepatocellular carcinoma.
@en
P2093
Christian Müller
Florian Hucke
Harald Heinzl
Ivo Graziadei
Matthias Pinter
Michael Trauner
Wolfgang Sieghart
Wolfgang Vogel
P2860
P304
P356
10.1002/HEP.26256
P407
P577
2013-05-03T00:00:00Z